Immunoparesis status in immunoglobulin light chain amyloidosis at diagnosis affects response and survival by regimen type

Clinical tools to guide in the appropriate treatment selection in immunoglobulin light chain (AL) amyloidosis are not well developed. We evaluated the response and outcome for various regimens at first-line treatment (n=681) and first progression (n=240) stratified by the immunoparesis status at dia...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Haematologica
Main Authors: Muchtar, Eli, Dispenzieri, Angela, Kumar, Shaji K., Dingli, David, Lacy, Martha Q., Buadi, Francis K., Hayman, Suzanne R., Kapoor, Prashant, Leung, Nelson, Chakraborty, Rajshekhar, Russell, Stephen, Lust, John A., Lin, Yi, Go, Ronald S., Zeldenrust, Steven, Kyle, Robert A., Rajkumar, S. Vincent, Gertz, Morie A.
Format: Artigo
Jezik:Inglês
Izdano: Ferrata Storti Foundation 2016
Teme:
Articles
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5060027/
https://ncbi.nlm.nih.gov/pubmed/27479823
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2016.147041
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki